Takayuki Shiroyama

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Top Venues

Cancer research communications

Thoracic cancer

Respirology case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications 4 (1) (2024)
Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications 4 (1) (2024)
Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications (2024)
Takatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, Saori Amiya, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Natsuko Tokuhira, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh
COVID-19 in a human T-cell lymphotropic virus type-1 carrier. Clinical case reports 10 (2) (2022)
Kinnosuke Matsumoto, Takayuki Shiroyama, Kotaro Miyake, Yuji Yamamoto, Tomoki Kuge, Midori Yoneda, Makoto Yamamoto, Yujiro Naito, Yasuhiko Suga, Kiyoharu Fukushima, Shohei Koyama, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh
Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report. Medicine 101 (1) (2022)
Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Takatoshi Enomoto, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, Moe Koide, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19. Respirology case reports 9 (7) (2021)
Takayuki Niitsu, Takayuki Shiroyama, Kotaro Miyake, Yoshimi Noda, Kansuke Kido, Reina Hara, Takatoshi Enomoto, Yuichi Adachi, Saori Amiya, Yasuhiko Suga, Kiyoharu Fukushima, Syohei Koyama, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh
Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review. Thoracic cancer 11 (12) (2020)
Masaki Kanazu, Masahide Mori, Madoka Kimura, Kazumi Nishino, Takayuki Shiroyama, Izumi Nagatomo, Shoichi Ihara, Kiyoshi Komuta, Hidekazu Suzuki, Tomonori Hirashima, Toru Kumagai, Fumio Imamura
Effectiveness of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study. Thoracic cancer 12 (1) (2020)
Takayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, Akihiro Tamiya, Ayako Tanaka, Norio Okamoto, Kenji Nakahama, Yoshihiko Taniguchi, Shun-Ichi Isa, Takako Inoue, Fumio Imamura, Shinji Atagi, Tomonori Hirashima
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer. Cancer medicine 7 (1) (2017)